Drug FDA Class II Ongoing cGMP deviation

Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. NDC: 59651-137-30

Aurobindo Pharma USA Inc Published Dec 25, 2024

Risk level

Class II

May cause a temporary or reversible health problem; slight chance of serious harm.

Severity score 60/100

What should you do?

Check whether you have this product, using the lot codes, UPCs, and dates listed below.
Do not eat, serve, or sell the affected product.
Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
Contact Aurobindo Pharma USA Inc or your place of purchase with questions, and see the source record below for full details.

Reason for recall

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.

Hazards

N-Nitroso Nebivolol · primary

Affected products (1)

Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. NDC: 59651-137-30

NEBIVOLOL

NDC: 59651-137, 59651-138, 59651-139, 59651-140, 59651-137-30, 59651-137-90, 59651-138-30, 59651-138-90, 59651-139-30, 59651-139-90, 59651-140-30, 59651-140-90

Code info: Lot #: NB0224001A and NB0224001B, Exp. Date 04/2027

Affected areas

Nationwide

Timeline

Initiated

Dec 6, 2024
Published

Dec 25, 2024

Recall number: D-0149-2025
Agency: U.S. Food and Drug Administration
Country: US

Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.